FREDAX AB has a total of 43 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MABVAX THERAPEUTICS INC, ABBVIE STEMCENTRX LLC and LYKERA BIOMED SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United Kingdom | 4 | |
#5 | Brazil | 3 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Israel | 3 | |
#9 | Republic of Korea | 3 | |
#10 | Mexico | 3 | |
#11 | WIPO (World Intellectual Property Organization) | 3 | |
#12 | Hong Kong | 1 | |
#13 | Hungary | 1 | |
#14 | Japan | 1 | |
#15 | Serbia | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Tran Amanda Thuy | 32 |
#2 | Strand Sven-Erik | 27 |
#3 | Axelsson Sven-Niklas Anders | 11 |
#4 | Lamminmaki Urpo Juhani | 10 |
#5 | Lamminmäki Urpo Juhani | 9 |
#6 | Sjöström Kjell | 8 |
#7 | Timmermand Par Oskar Vilhelmsson | 7 |
#8 | Axelsson Anders | 7 |
#9 | Malmborg Hager Cecilia Ann-Christin | 6 |
#10 | Sjostrom Kjell | 5 |
Publication | Filing date | Title |
---|---|---|
CN108136013A | Antibody polypeptides and application thereof | |
GB201519105D0 | Antibody polypeptides and uses thereof | |
GB201517550D0 | Antibody polypeptides and uses thereof | |
EP3071595A1 | Humanised anti kallikrein-2 antibody | |
GB201401973D0 | Antibody polypeptides and uses thereof | |
GB201320408D0 | Antibody polypeptides and uses thereof | |
CN104159618A | Therapeutic agents and uses thereof |